Why Hims & Hers Heath Shares Are Surging Today
Why Hims & Hers Heath Shares Are Surging Today
Hims & Hers Health Inc. (NYSE:HIMS) shares are moving higher on Monday after the company appointed former Novo Nordisk COO and President Kåre Schultz's to its Board of Directors.
梯瓦製藥（NYSE: HIMS）股價週一有所上漲，此前該公司任命前諾和諾德COO和總裁Kåre Schultz入董事會。
Schultz brings extensive experience from his leadership roles at Novo Nordisk Inc. (NYSE:NVO), Teva Pharmaceutical Industries LTD (NYSE:TEVA) and Lundbeck.
Schultz在諾和諾德Inc.（NYSE:NVO）、董事會、及倫德貝克的領導角色帶來了豐富的經驗。
At Novo Nordisk, Schultz was instrumental in establishing the company as a leader in diabetes care.
在諾和諾德工作期間，Schultz成爲確立公司成爲糖尿病護理領袖的關鍵人物。
"Kåre's experience gives us an incredible wealth of expertise as we bring together the most valuable elements of clinical excellence, healthcare and technology to redefine health and wellness for our customers." said CEO Andrew Dudum.
“Kåre的經驗爲我們帶來了難以置信的專業知識，因爲我們整合了臨床卓越、醫療保健和技術的最有價值的元素，重新定義了我們客戶的健康和福利。”首席執行官Andrew Dudum說。
Price Action: Hims & Hers shares were up by 5.12% at $20.50 at the time of writing, according to Benzinga Pro.
根據Benzinga Pro的數據，在撰寫本文時，Hims&Hers股價上漲了5.12%，報20.50美元。
- Biden's Exit From Presidential Race 'Yet Another Curveball For Equity Investors': Analysts
- 拜登退出總統競選對股本投資者是“又一個曲球”：分析師
Image: Courtesy of Hims & Hers Health, Inc.
圖片：Hims&Hers Health, Inc.提供。
譯文內容由第三人軟體翻譯。